Positionaltrade
AVTNPL Showing Good MomentumNSE:AVTNPL
............................................................................................................................................................................................................................................
Products
The main products of the Co. are - Marigold Extracts for Eye Care, Food Coloring & Poultry Pigmentation; Spice oleoresin and Oils for Food Coloring and Flavoring; Value added Teas - Decaffeinated Teas and Instant Teas; Animal Nutrition Products; and Rosemary extract.
............................................................................................................................................................................................................................................
Subsidiaries
The Co. has 2 wholly owned subsidiaries, namely AVT Natural Europe Ltd. & AVT Natural S.A. De C.v., Mexico. AVT Natural Europe Ltd. is the marketing arm of the Company for decaffeinated tea and instant tea. AVT Natural SA DE C.V, Mexico has been established with an aim to capture the market for the Animal Nutritional products in the South American market and other markets.
............................................................................................................................................................................................................................................
RUPA indicating is No More an Ordinary Underwear BrandNSE:RUPA
Commenting on the financial performance Mr. Vikash Agarwal - Whole Time Director, said,
“We are pleased to report a stable performance in Q1 FY25, though the industry continues to witness resistance to any price increase. We
demonstrated steady improvements across key financial metrics. This quarter, we witnessed 8% rise in revenue, primarily driven by strong sales in our
core product line. Our volume growth for the quarter reached 9%, supported by strong sales in the economy and athleisure segments.
Our EBITDA saw a year-on-year increase of 59%, totaling Rs. 18.0 crores for the quarter, showcasing our commitment to cost management and
operational efficiency. Operating margins also improved by 280 basis points compared to the same period last year. Furthermore, our net profit
experienced substantial growth of 149%, reaching Rs. 10.5 crores for the quarter. This underscores the effectiveness of our financial strategies and the
resilience of our business model. Net profit margins improved by 280 basis points during the quarter.
Notably, our exports have shown progress, with a healthy 32% year-on-year growth, reaching Rs. 8 crores. This reflects our steady penetration into
international markets. Revenue contribution from Modern Trade remains robust at 8% in Q1 FY25.
The pilot project “Pragati’, which was launched last quarter, has received encouraging feedback from our distributors. We expect healthy expansion of
the project going forward.
Our cash flow from operations remains strong, generating Rs. 44 crores in Q1 FY25. We have made significant progress in reducing our debt, achieving
a net debt-free status as at end of Q1 FY25. Our branding and advertising strategies accounted for 9% of revenues in Q1 FY25.
Looking ahead, we are confident in achieving new business milestones and delivering innovative products to our diverse customer segments. Our
customer-first approach will help us strengthen our position as an industry leader and contribute to our sustainable business model
KOPRAN Showed Breakout with Huge Volume at 52 Weeks High ZoneNSE:KOPRAN
The co. has set up a new API plant at Panoli, commercial production at this facility is expected to be started from Q3 FY25. In FY23, it completed upgradation and expansion of the multi-product plant at the Mahad facility for existing products and to manufacture new molecules.
An integrated Pharmaceutical Company, committed to supplying International
Quality Formulations and Active Pharmaceutical Ingredients (APIs) globally.
State-of-the-art manufacturing facilities and products with various accreditations
and approvals by major global regulatory authorities.
The formulations vertical is operated through Kopran Limited.
The API vertical is being operated under Kopran Research Laboratories Ltd.
(KRLL), a wholly owned subsidiary of Kopran Limited
INDOAMIN Showing Volume Strength near ALL TIME HIGH Zone NSE:INDOAMIN
Strengths:
Established market position: IAL was promoted by Mr Vijay B Palkar in 1979, as Techno Chemical Industries, and converted to IAL in 1992. Over the years, the promoters have developed strong expertise in the chemical industry. The company now manufactures oleo, specialty and performance chemicals, used across various industries, such as pharmaceuticals, agrochemicals, fertilizers, petrochemicals, pesticides and perfumeries. Benefits from the longstanding presence of the promoters in the chemical industry and their established relationships with customers and suppliers will continue over medium term.
Above average financial risk profile: The financial risk profile is above average with a robust net worth of around Rs. 213.86 crore as on March 31, 2023. This supports the financial flexibility of the group. Supported by a robust net worth the capital structure is moderate with total outside liabilities to adjusted networth (TOLANW) of 1.72 time as on March 31, 2023. This is expected to remain comfortable going forward. Capital structure is expected to improve over medium term on the back of healthy accruals, absence of large debt funded capex and scheduled repayments. Overall financial risk profile is expected to further improve over medium term.
EPL Just Have Broken 52 Week's HighNSE:EPL
Double digit revenue growth at 10.7%. All regions delivered strong growth.
Continued EBITDA margin improvement with Q1FY25 margin at 19.1%, an expansion of 160 bps YoY.
Absolute EBITDA grew by 20.8% YoY.
Adjusted PAT (excluding base year one off) has grown by 35.4% YoY. Reported PAT has grown by 18.2%.
Net Debt/EBITDA ratio improved to 0.67x vs 0.71x (YoY).
Return on Capital Employed (‘ROCE’) increased to 15.9% with YoY increase of 190 bp.
Company Profile
EPL manufactures multilayer plastic laminated collapsible tubes, providing specialty packaging solutions to the fast-moving consuming goods sector. EPL has 21 manufacturing plants in 11 countries across the world; the company commissioned a greenfield manufacturing unit in Brazil in FY23, with operations already getting ramped up at that unit.
PVR has reached its cheapest price ever PVR has fulfilled his overvalued price. 40% reduced from all time high and this is too much cheap in nature. DO SIP or invest doesn't matter, do whatever you want
Fair value has come and we may invest now .
1st target will be around 18% and 2nd one is 28%.
ENTRY PRICE 1340
TARGET 1 1590 (18%)
TAEGET 2 1720 (28%)
BACKUP PLAN if you will have some profits in your hand you should CREATE TRAILING GTT order to breakeven or COST TO COST entry price. don't be so greedy.
see you soon
B.L Kashyap & Sons Increasing Strength Can Be Held For Long-TermB.L.Kashyap & Sons Ltd is an EPC company engaged in the business of Construction of Buildings High-Rise Residential and Commercial Complexes, IT Parks, Institutional Buildings.
Total: 1,733.68 Cr Order value
Company has delivered good profit growth of 71.0% CAGR over last 5 years
Projects
• More than three decades of rich expertise.
• Completed 250 + projects and more than
140 million sq. ft.
Design Build Projects
• National High-Speed Railways
• Sabarmati Station
• DLF Downtown
• Embassy Flipkart
• Redevelopment of Gomti Nagar Station
• Hero Honda Motor Plant
• Jaipur & Chennai Metro
Company coming out of CDR – Moving towards Zero
Debt
• In the light of global meltdown during 2010 -13
operations of BLK were impacted resulting in
stress on the company
• BLK entered CDR in 2014
• Currently the company has no long-term debt and
has pared its consolidated debt.
• Reduction of Debt from 700 to ~ 270
• Currently the company only has CC and BG limits
De-risking business model – Residential to Commercial & Governmen
• Company has been awarded total orders during financial year 2022-23 to the
tune of Rs. 818.9 Cr
• The order book closed at Rs. 2402 crore for the year ended March 31, 2023
• Orders worth approx. INR 658 crore and INR 247 crore awarded during the first
and second quarter of FY2023 - 24
• Ending 30th June 2023 and the order book stood at approx. Rs. 2838 cr.
• Total Order Book stands at Rs. 3005 Cr as of September 2023
• During the quarter, orders were received across multiple segments like railways,
business parks, educational institutions, and residential complex
Growth driven to Profitability focus
• The company has planned capex of approximately
INR 25 crores during FY24. Capex for FY22 and FY23
was Rs. 8 Cr and Rs. 19 Cr respectively
• BLK is looking at increasing its footprint in the
infrastructure space related to its core business,
which is high quality structures and their associated
works.
SUZLON Entering 14 Years High ZoneCompany has reduced debt.
Company is almost debt free.
Company has delivered good profit growth of 19.7% CAGR over last 5 years
Strengths:
Stable cash flow from the O&M services business to support overall debt servicing: The Group has ~14.5 GW of installed fleet under O&M business as on Dec 31, 2023. While the fleet under O&M reduces with decommissioning of WTGs, post completion of the design life, new wind turbine generators delivered and commissioned get added to the fleet every fiscal. Revenue from O&M services has been steady as this is contractual activity over a fixed timeframe and at contracted price. Also, escalation in revenue is inbuilt into the contracts, ensuring stability of operating margin over a period. The Group has demonstrated stability in revenue and profitability of O&M services business even in stressed times in the past. Stable cash flow with EBIDTA above Rs 700 crore per fiscal from the O&M services business is expected going forward.
Leading market position in the wind turbine segment and a healthy order book: The Group has a successful track record of project execution with technical expertise, evident from the healthy market share of 30-35% in the WTG business in India over the past many years and also in cumulative installed capacity. The company’s healthy market position should help to obtain orders in the long run. SEL’s order book stood at ~3.16 GW (as on 31st Jan 24), to be executed till fiscal 2026. The company has been able to overcome the dependence on customer-backed financing to execute orders which had constrained growth in the last fiscal.
Improved financial risk profile: The term debt stood at Rs. 1,773 crores as on March 31, 2023, on the back of scheduled repayments of term loan and additional reduction of ~Rs 900 crores from rights issue in October 2022. Furthermore, the company’s networth turned positive as on March 31, 2023 on the back of refinancing (gain on derecognition of OCDs & CCPS) and rights issue of Rs 1,200 crores in fiscal 2023.
On August 14, 2023, the company approved the allotment of equity shares to Qualified Institution buyers aggregating to ~Rs. 2,000 crores. The company subsequently utilized the required amount to repay its entire debt at SEL, significantly improving the financial risk profile of the company. Further, SEL does not have material debt funded capex plans over medium term.
SAREGAMA INDIA LTD have Broken its Long Retrestment LevelCompany is almost debt free.
Company has delivered good profit growth of 29.6% CAGR over last 5 years
Company has been maintaining a healthy dividend payout of 36.0%
Company’s Operating Revenue for Q4 FY24 stood at Rs 2,631 Mn growing at 29% both on YoY as well as QoQ basis, with a strong adjusted EBITDA of Rs.864 Mn registering a YoY growth of 40%.
Company delivered a PBT of Rs 760 Mn with a 31% YOY growth.
Company’s Revenue from operations for FY24 stood at Rs 8,030 Mn with a strong adjusted EBITDA
of Rs. 3,029 Mn with a margin of 38%.
Company delivered a PBT of Rs 2,708 Mn with a 34% Margin
and PAT of Rs 1,976 Mn for FY24
Key Operational Highlights:
➢ The company’s strong performance is led by growth in music licensing on account of strong
advertisement revenues driven by its investment in new music and the revenues generated
through the artist management vertical
➢ This quarter saw music release of A.R.Rahman and Diljit Dosanjh’s Chamkila, Ajay Devgn’s
Maidaan, Ram Charan and Kiara Advani’s Game Changer, Yami Gautam’s “Article 370”,
Mohanlal’s Malaikottai Valliban, Diljit Dosanjh single Love Ya, multiple songs by Bhojpuri star
Neelkamal, Pawan Singh and Gujrati’s No.1 singer Rakesh Barot.
➢ During the Quarter, Company released 290 plus Originals and Premium Recreations
across Hindi, Bhojpuri, Gujarati, Punjabi, Tamil, Telugu, Malayalam, Marathi and
Bengali languages. Company also released 2,000 plus derivatives (LoFi, Trap Mix,
Cover, Acoustic etc.) which is driving the popularity and growth of its catalogue.
➢ The other highlight of the quarter was the use of our songs for Shahid Kapoor and Kriti Sanon
starrer 'Teri Baaton Mein Aisa Ulhja Jiya' (Hindi), for Mahesh Babu’s 'Guntur Karam’(Telugu),
for Dulquer Salmaan’s'King of Kotha’ (Malayalam) etc. and by brands like HUL Lux, Meesho,
Junglee Rummy, Andrex etc. in their ad films.
➢ Riding on the success of its Tamil Serial “Ilakkiya”, Company started its Malayalam remake
“Mangalyam Thanthunanena” on Surya Tv. We released “Crushed Season 4” series from Dice
of Pocket Aces on Amazon mini-TV.
➢ In Q4FY24 Yoodlee released Mohanlal starrer “Malaikottai Vaaliban” , Tovino Thomas starrer
“Anweshippin” in Malayalam and Gippy Grewal “Warning 2” in Punjabi.
➢ Digital footprint across Saregama owned and controlled channels touched 239Mn followers
and subscribers across YouTube, Instagram and Facebook.
EMAMI LTD SWING TRADE FOR COMING 3-6 MONTHS1.Bullish Chart Pattern is Forming on Higher TF of Weekly & Monthly
2. Kind Of H&S Pattern is getting structured
3. Currently Trading at Monthly Demand Zone of 450-460
4. Filled a gap on Daily TF
5. Bullish Engulfing on Daily TF with Heavy Volume
6. Fundamentals and company business is intact and showing growth consistently with Profits
7. Share Holding Pattern is also strong among big players & Institutions.
Buy @ 460-465
Stop Loss - 445
Target- 1st- 600 2nd- 700 & 3rd & Final- 900
View Holding For Next 3-9 Months
FORMATION OF DOUBLE BOTTOM: PRAJ IND1. Identifying the Downtrend:
A downtrend is characterized by a series of lower highs and lower lows. Upon analyzing the price chart of Praj Industries, it's evident that the stock has been declining over a certain period. This downtrend is marked by a consistent pattern of lower highs and lower lows, indicating selling pressure and overall bearish sentiment in the market.
2. Double Bottom Formation:
e observe the formation of a double bottom pattern within this downtrend. A double bottom pattern is a bullish reversal pattern that typically forms after an extended downtrend and signifies a potential trend reversal. In the case of NSE:PRAJIND , we identify two distinct troughs (bottoms) formed at approximately the same price level, separated by a peak (intermediate high). This formation suggests that selling pressure may be waning, and buyers are stepping in at the same support level twice, indicating a potential shift in sentiment from bearish to bullish.
3. Confirmation and Trade Setup:
To confirm the validity of the double bottom pattern and initiate a trade, we look for a breakout above the neckline. The neckline is drawn by connecting the highs between the two troughs of the double bottom pattern. Once the candle closes above the neckline, it serves as confirmation of the pattern completion and signals a potential entry point for a long trade.
4. Target Projection:
The target for the trade can be estimated by measuring the distance from the lowest low (bottom) of the double bottom pattern to the neckline. This distance is then added to the breakout point (the neckline) to project a potential upside target.
Follow-Up Analysis on FSL: Confirmation of Pennant BreakoutBuilding upon the analysis conducted yesterday, it is observed that NSE:FSL stock has successfully experienced a breakout upside from the Pennant pattern. Today's price action has confirmed the Pennant pattern breakout, signaling a continuation of the prevailing uptrend. The breakout is characterized by a decisive move above the upper trendline of the Pennant, validating the technical analysis shared in the previous report.
Target Projection:
The target for this trade can be estimated by measuring the height of the pole formed before the Pennant pattern. The pole is the strong, vertical price movement that precedes the consolidation phase. To calculate the target, this measured distance is then added to the breakout point.
To protect against adverse price movements, a strict stop-loss order should be implemented. The stop-loss level is determined based on the characteristics of the Pennant pattern and should be placed just below the lower trendline of the pattern.
EASEMYTRIP towards 55 levelsIn the Latest, ease my Trip has been seen taking support around 40 levels twice in the past few months.
First in the month of March 2023, and second in July 2023.
Now, if it sustains above 40 levels, it is most likely to move towards 55 levels in the coming months.
Immediate weekly resistance is around 48 levels.
WIPRO- Hourly/Daily/Weekly Timeframe-Channel/Tringle patternNSE:WIPRO
WIPRO has beaten so badly in last few months. The stock is near major support levels. The Sellers are trying to push it however somehow it is holding its levels.
Weekly : It has formed double bottom (355-360 level) at the bottom of the channel. As per weekly chart 370-380 was earlier resistance from where we saw sharp buying. Now it is retesting these levels and holding it from past 2 days. Besides it’s a .5 Fib level as well.
Daily : On 26th June there is a rejection from the bot (Hammer) which indicates 370-373 is strong support levels.
Hourly : From past 3 days it’s consolidating between 378-390 in tringle pattern. On Friday 30th June if we see a bullish price action near these levels it’s the best time to go long with small SL.
For positional traders SL should be around 370.
This is only for educational purpose, please manage your risk accordingly.